查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994357

功能性近紅外線腦部造影市場：依產品類型、組件、波長範圍及應用分類－2026年至2032年全球市場預測

Functional Near-infrared Optical Brain Imaging Market by Product Type, Components, Wavelength Range, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，功能性近紅外線光學腦成像市場價值將達到 2.1915 億美元，到 2026 年將成長至 2.3377 億美元，到 2032 年將達到 3.722 億美元，年複合成長率為 7.86%。

主要市場統計數據
基準年 2025 2.1915億美元
預計年份：2026年 2.3377億美元
預測年份 2032 3.722億美元
複合年成長率 (%) 7.86%

這份基礎文件簡明扼要地說明了影響當前功能性近紅外線腦部造影趨勢的技術促進因素、應用範圍和生態系統動態。

功能性近紅外線腦部造影（fNIRS）正從一項小眾調查方法發展成為一個功能全面的平台，支援轉化神經科學、臨床工作流程和消費級腦機介面。本文概述了現代技術組件、核心應用領域以及不斷發展的供應商、整合商和終端用戶生態系統。該技術的非侵入性和相對較高的運動容錯性使其應用範圍從實驗室擴展到臨床環境、復健中心和應用研究領域。

設備架構、組件創新和演算法進步等方面的技術融合如何重塑產品權衡，並使其能夠在現實世界環境中部署。

功能性近紅外線光學腦成像領域正經歷一場變革，其驅動力來自跨學科創新和不斷變化終端用戶的需求。連續波、頻域和時域儀器的進步不僅提高了測量精度，也重新定義了設備的外形尺寸和工作環境。連續波系統變得更加節能緊湊，頻域儀器透過相位解析度測量提高了深度解析度，而時域平台則不斷突破光子飛行時間解析度的極限。這些模式的創新相結合，在複雜性、便攜性和生理解析度之間形成了多種權衡，各機構必須認真考慮這些因素。

本檢驗了2025 年關稅變化如何加速了整個成像生態系統的供應鏈韌性措施、模組化設計的採用以及區域製造調整。

美國於2025年實施的關稅對功能性近紅外線光學腦成像生態系統中相關人員的供應鏈和採購產生了切實的影響。關稅帶來的成本壓力影響了進口組件，例如專用檢測器、光纖和高精度光源，迫使採購團隊重新評估其供應商組合和採購區域。因此，設備製造商加快了雙重採購策略的實施，並加強了與供應商的合作，以降低對單一國家依賴的風險，並減少關稅波動的影響。

將設備模式、組件架構和特定應用要求與策略性產品選擇和檢驗優先順序連結起來的詳細細分觀點。

市場區隔洞察揭示了影響產品開發、商業化選擇和研究重點的微妙權衡。依產品類型，市場可分為三大類：連續波、頻域、時域。這些模式的差異直接影響儀器的複雜性、校準要求和應用適用性。連續波方法因其緊湊性和成本效益，通常適用於消費級腦機介面和一些神經復健應用；而頻域和時域系統則提供更高的深度解析度和定量指標，這些指標與臨床診斷和高級認知研究密切相關。

美洲、歐洲、中東和非洲以及亞太地區的區域管理體制、研究生態系統和製造能力在部署策略方面有何不同？

區域趨勢為功能性近紅外線光學腦成像領域的機構創造了獨特的機會和營運考量。在美洲，強大的臨床研究網路、活躍的私人投資環境以及完善的復健服務體系，為技術快速部署到臨床試驗和試點應用提供了支援。監管環境強調臨床效用和安全性方面的證據，而報銷因素也日益影響機構對成人和兒童診斷應用的優先排序。因此，將臨床夥伴關係和以結果主導的檢驗納入其商業化策略的公司，將更容易找到合適的部署途徑。

參與企業如何平衡垂直整合、利基專業化和服務導向的商業化，以加速市場接受度並保持競爭優勢？

功能性近紅外線光學腦成像領域的企業級發展趨勢表明，垂直整合和協同專業化都是關注的重點。成熟的醫療設備製造商通常透過將組件製造、系統整合和臨床檢驗置於單一營運架構下來實現垂直整合，以確保品管、加快監管申報流程並保護智慧財產權。同時，敏捷的Start-Ups和專業供應商則專注於與大型合作夥伴授權或共同開發的創新技術，例如緊湊型檢測器、先進光源和人工智慧驅動的訊號處理模組。

為市場領導建立具有韌性的供應鏈、加速臨床檢驗以及創建互通性的、服務主導的商業化模式提供切實可行的策略步驟。

產業領導者必須採取切實可行的策略來應對技術複雜性、監管變化以及終端用戶不斷變化的需求。首先，應優先考慮模組化系統設計，以便快速更換檢測器、光纖和光源，從而減少對單一供應商的依賴，並在組件變更時加快監管部門的重新檢驗。其次，應與醫院和研究中心合作，將臨床檢驗融入產品開發的早期階段，產生可重複的結果數據，以消除支付者和臨床醫生的擔憂。

透過整合與專家的初步訪談、技術評估和供應鏈分析，我們透過高度透明和多方面的調查方法得出經過檢驗的策略見解。

本執行摘要的調查方法透過整合多面向證據、跨領域專家訪談和嚴謹的技術評估，確保了分析的可靠性和實用性。主要資訊來源包括對學術研究人員、臨床醫生、採購負責人和醫療設備工程師的結構化訪談，旨在收集關於器材權衡、臨床需求和推廣障礙的不同觀點。次要資訊來源包括同行評審文獻、技術白皮書、監管指南和專利趨勢，旨在檢驗技術進步並識別新興創新叢集。

綜合觀點強調，技術選擇、嚴格檢驗和營運彈性將決定未來幾年主導臨床和商業性應用的參與者。

總之，功能性近紅外線光學腦部造影正處於轉折點，技術成熟度、切實可行的商業化策略以及不斷變化的監管預期相契合，預計將被臨床醫生和消費者更廣泛地採用。儀器模式的選擇——連續波、頻域或時域——與組件架構和應用需求相互作用，共同塑造了獨特的價值提案格局。同時，關稅等政策變化凸顯了健全的採購體系、模組化設計和區域製造柔軟性的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 功能性近紅外線光學腦部造影市場：依產品類型分類

  • 連續波
  • 頻域
  • 時域

第9章 功能性近紅外線光學腦造影市場：依組件分類

  • 檢測器
    • 光電二極體
    • 光電倍增管
  • 光纖元件
    • 檢測光纖
    • 光纖光源
  • 光源
    • 雷射
    • LED

第10章：波段範圍分類的功能性近紅外線腦部造影市場

  • 650～900 nm
  • 900～1,000 nm
  • 1000奈米或更大

第11章 功能性近紅外線腦部造影市場：按應用領域分類

  • 腦機介面
    • 輔助技術
    • 遊戲與娛樂
  • 臨床診斷
    • 成人診斷
    • 兒童診斷
  • 認知調查
    • 人機互動
    • 神經科學研究
  • 神經復健
    • 運動功能障礙復健
    • 中風復健

第12章 功能性近紅外線腦部造影市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 功能性近紅外線腦部影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 功能性近紅外線腦部影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國功能性近紅外線腦部影像市場

第16章：中國功能性近紅外線光學腦部影像市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Artinis Medical Systems BV
  • BIOPAC Systems, Inc.
  • Gowerlabs Ltd
  • Hamamatsu Photonics KK
  • Hitachi, Ltd
  • ISS, Inc.
  • Kernel Flow Inc.
  • NIRx Medizintechnik GmbH
  • Shimadzu Corporation
  • TechEn, Inc.
Product Code: MRR-1A1A064C05BB

The Functional Near-infrared Optical Brain Imaging Market was valued at USD 219.15 million in 2025 and is projected to grow to USD 233.77 million in 2026, with a CAGR of 7.86%, reaching USD 372.20 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 219.15 million
Estimated Year [2026] USD 233.77 million
Forecast Year [2032] USD 372.20 million
CAGR (%) 7.86%

A concise foundation describing technological enablers, application breadth, and ecosystem dynamics shaping the current trajectory of functional near-infrared optical brain imaging

Functional near-infrared optical brain imaging (fNIRS) is maturing from a niche research modality into a versatile platform that supports translational neuroscience, clinical workflows, and consumer-oriented brain computer interfaces. This introduction outlines the contemporary technological building blocks, core application areas, and the evolving ecosystem of suppliers, integrators, and end users. The modality's noninvasive nature and relative tolerance to motion have expanded attention beyond laboratory settings and into clinics, rehabilitation centers, and applied research contexts.

Technological advances in light sources, photodetectors, and signal processing algorithms have improved temporal stability and depth sensitivity, enabling more robust interpretation of hemodynamic signals. At the same time, the convergence of miniaturized hardware, cloud-native analytics, and multimodal data fusion has created new possibilities for continuous monitoring and closed-loop interventions. Regulatory maturation and a growing emphasis on reproducibility in neuroscience contribute to broader institutional adoption, while interest from adjacent markets such as assistive technologies and gaming fuels private-sector innovation.

This introduction frames the remainder of the executive summary by emphasizing how technological capabilities, application demand, and an expanding supply chain interplay to shape near-term strategic choices. It prepares the reader to examine transformative shifts, tariff impacts, segmentation nuances, regional differentiators, and company-level strategies that collectively inform actionable priorities for leaders in this rapidly evolving field.

How technological convergence across instrument architectures, component innovation, and algorithmic advances is reshaping product tradeoffs and enabling real-world deployments

The landscape for functional near-infrared optical brain imaging is undergoing transformative shifts driven by cross-disciplinary innovation and changing end-user expectations. Advances in continuous wave, frequency domain, and time domain instrumentation are not only improving measurement fidelity but are also redefining device form factors and use environments. Continuous wave systems have become more energy efficient and compact, frequency domain instruments have improved depth discrimination via phase-resolved measurements, and time domain platforms continue to push the envelope in terms of photon time-of-flight resolution. Together, these modality innovations create a spectrum of tradeoffs between complexity, portability, and physiological resolution that organizations must navigate.

Moreover, improvements in component-level technologies such as detectors, fiber optics, and light sources are enabling smaller, more integrated systems with lower power consumption. Photodiodes and advanced solid-state photomultipliers are enhancing sensitivity, while laser and LED source innovations are expanding wavelength stability and safety margins. Concurrently, machine learning-based signal processing and artifact rejection techniques are increasing the reliability of hemodynamic interpretations across diverse populations and motion conditions. These algorithmic advances facilitate real-world deployments, from clinic to community settings, by reducing the need for controlled laboratory conditions.

Finally, commercial dynamics are shifting as partnerships between device manufacturers, software providers, and clinical institutions deepen. This institutionalization fosters standardized protocols, interoperability expectations, and clearer pathways for validation and reimbursement. As a result, the field is moving from pilot-driven curiosity toward scalable clinical and consumer applications, and organizations that align product development with interoperable standards and validated clinical workflows will capture disproportionate strategic advantage.

Examining how 2025 tariff shifts accelerated supply chain resilience measures, modular design adoption, and regional manufacturing adjustments across the imaging ecosystem

The imposition of United States tariffs in 2025 created tangible supply chain and procurement implications for participants in the functional near-infrared optical brain imaging ecosystem. Tariff-driven cost pressures affected imported components such as specialized detectors, optical fibers, and precision light sources, prompting procurement teams to reassess vendor portfolios and sourcing geographies. In turn, device manufacturers accelerated dual-sourcing strategies and closer supplier integration to mitigate the risk of single-country dependence and reduce exposure to tariff volatility.

As a consequence, organizations increasingly emphasized design for supply chain resilience, adopting modular architectures that permit component substitution without extensive redesign. This transition to modularity enhanced flexibility when qualifying alternative suppliers and reduced time-to-re-certification for functional subsystems. Additionally, procurement teams scrutinized total landed cost and lifecycle maintenance implications, shifting some purchasing priorities from lowest-cost bids toward partners with proven quality control, regulatory traceability, and logistics reliability.

Moreover, the tariffs catalyzed regional manufacturing decisions and localized assembly strategies. Some stakeholders expanded manufacturing or final-assembly operations in regions less impacted by tariff constraints to preserve price competitiveness for end customers. At the same time, tariff-related uncertainty reinforced the importance of long-term supplier contracts and strategic inventory management, with organizations balancing the costs of safety stock against the operational complexity of larger warehouses. Ultimately, the tariff environment of 2025 highlighted that policy shocks can accelerate structural shifts in sourcing strategies and design philosophies across the sector.

In-depth segmentation perspective connecting instrument modalities, component architectures, and application-specific requirements to strategic product choices and validation priorities

Segmentation insights reveal the nuanced tradeoffs that shape product development, commercialization choices, and research priorities. Based on Product Type, the market is studied across Continuous Wave, Frequency Domain, and Time Domain, and this modality differentiation directly influences instrument complexity, calibration requirements, and application suitability. Continuous Wave approaches typically favor compactness and cost-efficiency, making them attractive for consumer-facing brain computer interfaces and some neurorehabilitation contexts, whereas Frequency Domain and Time Domain systems provide enhanced depth resolution and quantitative metrics that align closely with clinical diagnostics and advanced cognitive research.

Based on Components, the market is studied across Detector, Fiber Optic Components, and Light Source. The Detector is further studied across Photodiode and Photomultiplier Tube, with photodiodes offering robustness and low power consumption that support wearable applications and photomultiplier tubes delivering superior sensitivity for high-resolution laboratory or clinical diagnostics. The Fiber Optic Components is further studied across Detector Fibers and Source Fibers, and fiber selection impacts signal throughput, probe ergonomics, and sterilization protocols in clinical settings. The Light Source is further studied across Laser and Led, and the choice between laser and LED sources affects wavelength precision, safety classification, and cost structure.

Based on Application, the market is studied across Brain Computer Interfaces, Clinical Diagnostics, Cognitive Research, and Neurorehabilitation. The Brain Computer Interfaces is further studied across Assistive Technologies and Gaming & Entertainment, each with distinct user experience and regulatory considerations. The Clinical Diagnostics is further studied across Adult Diagnostics and Pediatric Diagnostics, reflecting divergent physiological baselines and clinical workflow requirements. The Cognitive Research is further studied across Human Computer Interaction and Neuroscience Research, both driving different data quality and temporal resolution needs. The Neurorehabilitation is further studied across Motor Disorder Rehabilitation and Stroke Rehabilitation, applications that impose specific requirements for portability, real-time feedback, and integration with therapeutic regimens. These layered segmentation lenses clarify where design tradeoffs and commercialization strategies must align to deliver credible value propositions.

How regional regulatory regimes, research ecosystems, and manufacturing capabilities create distinct strategies for deployment across Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics create differentiated opportunity spaces and operational considerations for organizations in functional near-infrared optical brain imaging. In the Americas, strong clinical research networks, an active private investment landscape, and well-established rehabilitation services support rapid technology translation into clinical trials and pilot deployments. The regulatory environment emphasizes evidence of clinical utility and safety, and reimbursement considerations increasingly shape how organizations prioritize adult and pediatric diagnostic applications. Consequently, companies that integrate clinical partnerships and outcomes-driven validation into their commercialization strategies will find more receptive adoption pathways.

In Europe, Middle East & Africa, the ecosystem is characterized by diverse regulatory regimes and a pronounced emphasis on harmonization and standards. Pan-European research consortia and centralized funding mechanisms enable multicenter validation studies that amplify scientific credibility. At the same time, Middle Eastern and African markets present uneven infrastructure and adoption curves, encouraging tailored deployment strategies and partnerships with regional healthcare providers. These geographic nuances mean that product modularity, multilingual software support, and flexible deployment options are critical for sustained success across the region.

In Asia-Pacific, rapid adoption of digital health technologies, growing manufacturing capabilities, and a dynamic research community create a fertile environment for both high-volume device production and large-scale trials. Investment in local supply chains and component sourcing is common, and regional regulatory pathways are evolving to accommodate digital and AI-enabled diagnostics. As a result, organizations that align manufacturing strategy with regional compliance, local clinical validation, and culturally relevant user experience design will be better positioned to capture long-term engagement across diverse Asia-Pacific markets.

How market participants balance vertical integration, niche specialization, and service-oriented commercialization to drive adoption and sustain competitive advantage

Company-level dynamics in the functional near-infrared optical brain imaging sector demonstrate a dual emphasis on vertical integration and collaborative specialization. Established medical device firms often pursue vertical integration by bringing component manufacturing, system integration, and clinical validation under the same operational umbrella to control quality, accelerate regulatory submissions, and protect intellectual property. At the same time, nimble startups and specialized suppliers focus on discrete innovations-such as compact detectors, advanced light sources, or AI-driven signal processing modules-that can be licensed or co-developed with larger partners.

Licensing models and strategic partnerships remain central to scaling complex products that require clinical acceptance and software maturity. Many companies adopt hybrid commercialization strategies that combine direct sales for clinical customers with channel partnerships for research institutions and consumer markets. Furthermore, service-based revenue models-such as cloud analytics subscriptions, device-as-a-service offerings, and managed clinical trials-are emerging as ways to stabilize recurring income and deepen customer engagement. These models also create opportunities for lifecycle upgrades and data-driven validation that reinforce long-term value propositions.

Finally, corporate strategies increasingly prioritize evidence generation and interoperability. Firms that invest in robust clinical validation, conform to emerging data standards, and provide APIs for integration with electronic health records and third-party analytics platforms build stronger cases for adoption. In short, company success will depend on the ability to combine technical differentiation with pragmatic partnerships and sustainable commercialization models.

Practical strategic steps for market leaders to build resilient supply chains, accelerate clinical validation, and create interoperable, service-led commercialization models

Industry leaders must adopt pragmatic, actionable strategies to navigate technological complexity, regulatory variability, and evolving end-user expectations. First, prioritize modular system design that enables rapid substitution of detectors, fibers, and light sources to reduce dependency on single-source suppliers and to accelerate regulatory revalidation when components change. Second, embed clinical validation into early product development by partnering with hospitals and research centers to generate reproducible outcomes data that answers payer and clinician concerns.

Third, invest in algorithmic robustness and explainable models to ensure that signal processing advances translate into clinically interpretable endpoints. Robust analytics reduce user training burdens and support regulatory submissions, while explainability increases clinician trust. Fourth, pursue selective regional manufacturing or final assembly strategies to mitigate tariff exposure and shorten supply chain lead times. Localization should be balanced with global quality control to maintain device consistency across markets.

Fifth, cultivate interoperable software ecosystems through open APIs and standardized data formats to facilitate integration with electronic health records and third-party analytics. This interoperability drives adoption by reducing workflow friction. Finally, adopt flexible commercial models that combine capital sales with subscription-based analytics and service contracts to create recurring revenue and sustained customer engagement. Together, these recommendations provide a clear operational roadmap for leaders seeking to translate research momentum into durable market presence.

A transparent and triangulated methodology that blends primary expert interviews, technical assessments, and supply chain analysis to produce validated strategic insights

The research methodology underpinning this executive summary combined multi-source evidence synthesis, cross-functional expert interviews, and rigorous technical assessment to ensure analytical credibility and practical relevance. Primary inputs included structured interviews with academic investigators, clinical practitioners, procurement specialists, and device engineers to capture diverse perspectives on instrumentation tradeoffs, clinical needs, and implementation barriers. Secondary inputs encompassed peer-reviewed literature, technical white papers, regulatory guidance, and patent landscapes to validate technological trajectories and identify emergent innovation clusters.

Analytical techniques integrated component-level technical review with application-specific use case mapping to align product attributes with end-user requirements. Comparative assessments examined continuous wave, frequency domain, and time domain approaches alongside detector, fiber optic, and light source options to evaluate their suitability across clinical diagnostics, cognitive research, brain computer interfaces, and neurorehabilitation. Supply chain analysis incorporated tariff impacts, supplier concentration metrics, and manufacturing capabilities to assess vulnerability and resilience.

Finally, findings were iteratively validated through expert workshops that stress-tested assumptions and refined recommendations for decision-makers. This triangulated approach ensured that conclusions rest on convergent evidence rather than single-source assertions, delivering a robust foundation for strategic planning and operational execution.

A consolidated perspective emphasizing how technical choices, validation rigor, and operational agility will determine who leads clinical and commercial adoption in the coming years

In conclusion, functional near-infrared optical brain imaging stands at an inflection point where technical maturation, pragmatic commercialization strategies, and evolving regulatory expectations align to enable broader clinical and consumer adoption. Instrument modality choices-across continuous wave, frequency domain, and time domain-interact with component architectures and application requirements to create a landscape of distinct value propositions. Simultaneously, policy shifts such as tariffs have underscored the need for resilient sourcing, modular designs, and regional manufacturing flexibility.

As a result, organizations that combine rigorous clinical validation, interoperable software strategies, and flexible commercial models will be best positioned to capture long-term value. Collaboration between device manufacturers, software innovators, clinical institutions, and payers will accelerate meaningful outcomes and patient-centered applications. Ultimately, the future trajectory of this field will be determined less by a single technological breakthrough and more by the ability of stakeholders to operationalize evidence, standardize workflows, and sustainably deliver demonstrable clinical and user benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Functional Near-infrared Optical Brain Imaging Market, by Product Type

  • 8.1. Continuous Wave
  • 8.2. Frequency Domain
  • 8.3. Time Domain

9. Functional Near-infrared Optical Brain Imaging Market, by Components

  • 9.1. Detector
    • 9.1.1. Photodiode
    • 9.1.2. Photomultiplier Tube
  • 9.2. Fiber Optic Components
    • 9.2.1. Detector Fibers
    • 9.2.2. Source Fibers
  • 9.3. Light Source
    • 9.3.1. Laser
    • 9.3.2. Led

10. Functional Near-infrared Optical Brain Imaging Market, by Wavelength Range

  • 10.1. 650-900 nm
  • 10.2. 900-1,000 nm
  • 10.3. Above 1,000 nm

11. Functional Near-infrared Optical Brain Imaging Market, by Application

  • 11.1. Brain Computer Interfaces
    • 11.1.1. Assistive Technologies
    • 11.1.2. Gaming & Entertainment
  • 11.2. Clinical Diagnostics
    • 11.2.1. Adult Diagnostics
    • 11.2.2. Pediatric Diagnostics
  • 11.3. Cognitive Research
    • 11.3.1. Human Computer Interaction
    • 11.3.2. Neuroscience Research
  • 11.4. Neurorehabilitation
    • 11.4.1. Motor Disorder Rehabilitation
    • 11.4.2. Stroke Rehabilitation

12. Functional Near-infrared Optical Brain Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Functional Near-infrared Optical Brain Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Functional Near-infrared Optical Brain Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Functional Near-infrared Optical Brain Imaging Market

16. China Functional Near-infrared Optical Brain Imaging Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Artinis Medical Systems B.V.
  • 17.6. BIOPAC Systems, Inc.
  • 17.7. Gowerlabs Ltd
  • 17.8. Hamamatsu Photonics K.K.
  • 17.9. Hitachi, Ltd
  • 17.10. ISS, Inc.
  • 17.11. Kernel Flow Inc.
  • 17.12. NIRx Medizintechnik GmbH
  • 17.13. Shimadzu Corporation
  • 17.14. TechEn, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FREQUENCY DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FREQUENCY DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FREQUENCY DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY TIME DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY TIME DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY TIME DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTODIODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTODIODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTODIODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTOMULTIPLIER TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTOMULTIPLIER TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTOMULTIPLIER TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SOURCE FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SOURCE FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SOURCE FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 650-900 NM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 650-900 NM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 650-900 NM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 900-1,000 NM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 900-1,000 NM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 900-1,000 NM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ABOVE 1,000 NM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ABOVE 1,000 NM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ABOVE 1,000 NM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ASSISTIVE TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ASSISTIVE TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ASSISTIVE TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GAMING & ENTERTAINMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GAMING & ENTERTAINMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GAMING & ENTERTAINMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ADULT DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ADULT DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ADULT DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PEDIATRIC DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PEDIATRIC DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PEDIATRIC DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY HUMAN COMPUTER INTERACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY HUMAN COMPUTER INTERACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY HUMAN COMPUTER INTERACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROSCIENCE RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROSCIENCE RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROSCIENCE RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY MOTOR DISORDER REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY MOTOR DISORDER REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY MOTOR DISORDER REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY STROKE REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY STROKE REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 208. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 213. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 215. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 244. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 256. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-203